|
1
|
Lee SE, Lee AY, Park WJ, Jun DH, Kwon NS,
Baek KJ, Kim YG and Yun HY: Mouse LGI3 gene: Expression in brain
and promoter analysis. Gene. 372:8–17. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park WJ, Lee SE, Kwon NS, Baek KJ, Kim DS
and Yun HY: Leucine-rich glioma inactivated 3 associates with
syntaxin 1. Neurosci Lett. 444:240–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Park WJ, Lim YY, Kwon NS, Baek KJ, Kim DS
and Yun HY: Leucine-rich glioma inactivated 3 induces neurite
outgrowth through Akt and focal adhesion kinase. Neurochem Res.
35:789–796. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee SH, Jeong YM, Kim SY, Jeong HS, Park
KC, Baek KJ, Kwon NS, Yun HY and Kim DS: Ultraviolet B-induced LGI3
secretion protects human keratinocytes. Exp Dermatol. 21:716–718.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeong YM, Park WJ, Kim MK, Baek KJ, Kwon
NS, Yun HY and Kim DS: Leucine-rich glioma inactivated 3 promotes
HaCaT keratinocyte migration. Wound Repair Regen. 21:634–640. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim IW, Jeong HS, Kwon NS, Baek KJ, Yun HY
and Kim DS: LGI3 promotes human keratinocyte differentiation via
the Akt pathway. Exp Dermatol. 27:1224–1229. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jeong HS, Jeong YM, Kim J, Lee SH, Choi
HR, Park KC, Kim BJ, Baek KJ, Kwon NS, Yun HY and Kim DS:
Leucine-rich glioma inactivated 3 is a melanogenic cytokine in
human skin. Exp Dermatol. 23:600–602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kim HA, Kwon NS, Baek KJ, Kim DS and Yun
HY: Leucine-rich glioma inactivated 3 associates negatively with
adiponectin. Cytokine. 62:206–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HA, Park WJ, Jeong HS, Lee HE, Lee SH,
Kwon NS, Baek KJ, Kim DS and Yun HY: Leucine-rich glioma
inactivated 3 regulates adipogenesis through ADAM23. Biochim
Biophys Acta. 1821:914–922. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim HA, Kwon NS, Baek KJ, Kim DS and Yun
HY: Leucine-rich glioma inactivated 3 and tumor necrosis factor-α
regulate mutually through NF-κB. Cytokine. 72:220–223. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim HA, Kwon NS, Baek KJ, Kim DS and Yun
HY: Leucine-rich glioma inactivated 3: Integrative analyses support
its role in the cytokine network. Int J Mol Med. 40:251–259. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kwon NS, Baek KJ, Kim DS and Yun HY:
Leucine-rich glioma inactivated 3: Integrative analyses reveal its
potential prognostic role in cancer. Mol Med Rep. 17:3993–4002.
2018.PubMed/NCBI
|
|
13
|
Kwon NS, Kim DS and Yun HY: Leucine-rich
glioma inactivated 3: Integrative analyses support its prognostic
role in glioma. Onco Targets Ther. 10:2721–2728. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herbst RS, Morgensztern D and Boshoff C:
The biology and management of non-small cell lung cancer. Nature.
553:446–454. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu TP, Tsai MH, Lee JM, Hsu CP, Chen PC,
Lin CW, Shih JY, Yang PC, Hsiao CK, Lai LC and Chuang EY:
Identification of a novel biomarker, SEMA5A, for non-small cell
lung carcinoma in nonsmoking women. Cancer Epidemiol Biomarkers
Prev. 19:2590–2597. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res 43
(Database Issue). D447–D452. 2015. View Article : Google Scholar
|
|
18
|
Lopes CT, Franz M, Kazi F, Donaldson SL,
Morris Q and Bader GD: Cytoscape Web: An interactive web-based
network browser. Bioinformatics. 26:2347–2348. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee S, Zhang C, Liu Z, Klevstig M,
Mukhopadhyay B, Bergentall M, Cinar R, Ståhlman M, Sikanic N, Park
JK, et al: Network analyses identify liver-specific targets for
treating liver diseases. Mol Syst Biol. 13:9382017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Thomas-Chollier M, Hufton A, Heinig M,
Heinig M, O'Keeffe S, Masri NE, Roider HG, Manke T and Vingron M:
Transcription factor binding predictions using TRAP for the
analysis of ChIP-seq data and regulatory SNPs. Nat Protoc.
6:1860–1869. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Mizuno H, Kitada K, Nakai K and Sarai A:
PrognoScan: A new database for meta-analysis of the prognostic
value of genes. BMC Med Genomics. 2:182009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li H, Sun Y and Zhan M: Exploring pathways
from gene co-expression to network dynamics. Methods Mol Biol.
541:249–267. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rossi MR, Huntoon K and Cowell JK:
Differential expression of the LGI and SLIT families of genes in
human cancer cells. Gene. 356:85–90. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chernova OB, Somerville RP and Cowell JK:
A novel gene, LGI1, from 10q24 is rearranged and downregulated in
malignant brain tumors. Oncogene. 17:2873–2881. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan J, Yang Q, Shao J, Zhang L, Ma J, Wang
Y, Jiang BH, Leng J and Bai X: Cyclooxygenase-2 induced β1-integrin
expression in NSCLC and promoted cell invasion via the
EP1/MAPK/E2F-1/FoxC2 signal pathway. Sci Rep. 6:338232016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shintani Y, Fujiwara A, Kimura T, Kawamura
T, Funaki S, Minami M and Okumura M: IL-6 secreted from
cancer-associated fibroblasts mediates chemoresistance in NSCLC by
increasing epithelial-mesenchymal transition signaling. J Thorac
Oncol. 11:1482–1492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D
and Guan XY: High levels of CCL2 or CCL4 in the tumor
microenvironment predict unfavorable survival in lung
adenocarcinoma. Thorac Cancer. 9:775–784. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Song NY, Zhu F, Wang Z, Willette-Brown J,
Xi S, Sun Z, Su L, Wu X, Ma B, Nussinov R, et al: IKKα inactivation
promotes Kras-initiated lung adenocarcinoma development through
disrupting major redox regulatory pathways. Proc Natl Acad Sci USA.
115:E812–E821. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsuo N, Azuma K, Hattori S, Ohtake J,
Kawahara A, Ishii H, Tokito T, Yamada K, Shibata Y, Shimokawaji T,
et al: Association between soluble immune mediators and tumor
responses in patients with non-small cell lung cancer treated with
anti-PD-1 inhibitor. Int J Cancer. 144:1170–1179. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Tan X and Chen M: MYLK and MYL9 expression
in non-small cell lung cancer identified by bioinformatics analysis
of public expression data. Tumour Biol. 35:12189–12200. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eide HA, Halvorsen AR, Sandhu V, Fåne A,
Berg J, Haakensen VD, Kure EH, Brustugun OT, Kiserud CE, Kyte JA
and Helland Å: Non-small cell lung cancer is characterised by a
distinct inflammatory signature in serum compared with chronic
obstructive pulmonary disease. Clin Transl Immunology. 5:e1092016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Podgornik H, Sok M, Kern I, Marc J and
Cerne D: Lipoprotein lipase in non-small cell lung cancer tissue is
highly expressed in a subpopulation of tumor-associated
macrophages. Pathol Res Pract. 209:516–520. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eberlein C, Rooney C, Ross SJ, Farren M,
Weir HM and Barry ST: E-Cadherin and EpCAM expression by NSCLC
tumour cells associate with normal fibroblast activation through a
pathway initiated by integrin αvβ6 and maintained through TGFβ
signalling. Oncogene. 34:704–716. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Bren-Mattison Y, Van Putten V, Chan D,
Winn R, Geraci MW and Nemenoff RA: Peroxisome
proliferator-activated receptor-gamma (PPAR(gamma)) inhibits
tumorigenesis by reversing the undifferentiated phenotype of
metastatic non-small-cell lung cancer cells (NSCLC). Oncogene.
24:1412–1422. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang Z, Shen Q, Xie H, Zhou X, Li J, Feng
J, Liu H, Wang W, Zhang S and Ni S: Elevated expression of FABP3
and FABP4 cooperatively correlates with poor prognosis in non-small
cell lung cancer (NSCLC). Oncotarget. 7:46253–46262. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhong Z, Ye Y, Guo W, He Y and Hu W:
Relationship between DLK1 gene promoter region DNA methylation and
non-small cell lung cancer biological behavior. Oncol Lett.
13:4123–4126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gu W, Wevers A, Schröder H, Grzeschik KH,
Derst C, Brodtkorb E, de Vos R and Steinlein OK: The LGI1 gene
involved in lateral temporal lobe epilepsy belongs to a new
subfamily of leucine-rich repeat proteins. FEBS Lett. 519:71–76.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kumazoe M, Yamashita M, Nakamura Y,
Takamatsu K, Bae J, Yamashita S, Yamada S, Onda H, Nojiri T,
Kangawa K and Tachibana H: Green tea polyphenol EGCG upregulates
Tollip expression by suppressing Elf-1 expression. J Immunol.
199:3261–3269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kramer B, Wiegmann K and Kronke M:
Regulation of the human TNF promoter by the transcription factor
Ets. J Biol Chem. 270:6577–6583. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
DeKoter RP and Singh H: Regulation of B
lymphocyte and macrophage development by graded expression of PU.1.
Science. 288:1439–1441. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bevington SL, Cauchy P, Piper J, Bertrand
E, Lalli N, Jarvis RC, Gilding LN, Ott S, Bonifer C and Cockerill
PN: Inducible chromatin priming is associated with the
establishment of immunological memory in T cells. EMBO J.
35:515–535. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Corre S and Galibert MD: USF as a key
regulatory element of gene expression. Med Sci (Paris). 22:62–67.
2006.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Swain SD, Meissner NN, Siemsen DW,
McInnerney K and Harmsen AG: Pneumocystis elicits a
STAT6-dependent, strain-specific innate immune response and airway
hyperresponsiveness. Am J Respir Cell Mol Biol. 46:290–298. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Zhang Q, Lenardo MJ and Baltimore D: 30
Years of NF-κB: A blossoming of relevance to human pathobiology.
Cell. 168:37–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wen AY, Sakamoto KM and Miller LS: The
role of the transcription factor CREB in immune function. J
Immunol. 185:6413–6419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Oyama N, Iwatsuki K, Homma Y and Kaneko F:
Induction of transcription factor AP-2 by inflammatory cytokines in
human keratinocytes. J Invest Dermatol. 113:600–606. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ji Z, Erin CY, Kumar R, Taylor M, Jenny
Njauw CN, Miao B, Frederick DT, Wargo JA, Flaherty KT, Jönsson G
and Tsao H: MITF modulates therapeutic resistance through EGFR
signaling. J Invest Dermatol. 135:1863–1872. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Uzdensky AB, Demyanenko SV and Bibov MY:
Signal transduction in human cutaneous melanoma and target drugs.
Curr Cancer Drug Targets. 13:843–866. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Domagala-Kulawik J: The role of the immune
system in non-small cell lung carcinoma and potential for
therapeutic intervention. Transl Lung Cancer Res. 4:177–190.
2015.PubMed/NCBI
|
|
52
|
West NR, McCuaig S, Franchini F and Powrie
F: Emerging cytokine networks in colorectal cancer. Nat Rev
Immunol. 15:615–629. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Font-Burgada J, Sun B and Karin M: Obesity
and cancer: The oil that feeds the flame. Cell Metab. 23:48–62.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lam VK, Bentzen SM, Mohindra P, Nichols
EM, Bhooshan N, Vyfhuis M, Scilla KA, Feigenberg SJ, Edelman MJ and
Feliciano JL: Obesity is associated with long-term improved
survival in definitively treated locally advanced non-small cell
lung cancer (NSCLC). Lung Cancer. 104:52–57. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Xie HJ, Zhang X, Wei ZQ, Long H, Rong TH
and Su XD: Effect of body mass index on survival of patients with
stage I non-small cell lung cancer. Chin J Cancer. 36:72017.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Jackute J, Zemaitis M, Pranys D,
Sitkauskiene B, Miliauskas S, Vaitkiene S and Sakalauskas R:
Distribution of M1 and M2 macrophages in tumor islets and stroma in
relation to prognosis of non-small cell lung cancer. BMC Immunol.
19:32018. View Article : Google Scholar : PubMed/NCBI
|
